Mark Rus

Outlook Microsoft Office 365 Amazon AWS Mobile Friendly Vimeo Apache Render Remote

biotechnology research brain health neuroplasticity neuroplastogens mental health neurological treatments non-hallucinogenic compounds psychedelic research neurological conditions therapeutic options circuit-selective functional neuroplasticity structural neuroplasticity oral medications patient care neuropsychopharmacology neurodevelopmental disorders neuropsychiatric conditions novel therapeutics pharmacology clinical trials psychedelic analogs innovative solutions safe medication fast-acting treatments sustained therapy neuroscience innovation patient access scalable solutions brain disorders mental function improvement neuroplastic medicines research publications biomedical research therapeutics development drug discovery psychoplastogens psychedelic pioneer neuroscience team fda regulations evidence-based medicine healthcare solutions emerging therapies patient population unmet medical needs neurochemical pathways bioavailability therapeutic efficacy technological advancements hospital & health care health care health wellness & fitness